Company Registration No. 12983269 (England and Wales)
Northfield Pharmaceuticals Ltd
Unaudited accounts
for the year ended 31 October 2025
Northfield Pharmaceuticals Ltd
Unaudited accounts
Contents
Northfield Pharmaceuticals Ltd
Company Information
for the year ended 31 October 2025
Directors
Mr M A Daji
Mr M I Akudi
Company Number
12983269 (England and Wales)
Registered Office
10 Northfield Road
Dewsbury
West Yorkshire
WF13 2JX
England
Northfield Pharmaceuticals Ltd
Statement of financial position
as at 31 October 2025
Intangible assets
213,307
243,779
Tangible assets
1,040
1,387
Cash at bank and in hand
133,266
77,360
Creditors: amounts falling due within one year
(113,869)
(105,071)
Net current assets
160,766
99,772
Total assets less current liabilities
375,113
344,938
Creditors: amounts falling due after more than one year
(266,971)
(288,271)
Called up share capital
2
2
Profit and loss account
108,140
56,665
Shareholders' funds
108,142
56,667
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 11 September 2026 and were signed on its behalf by
Mr M A Daji
Director
Company Registration No. 12983269
Northfield Pharmaceuticals Ltd
Notes to the Accounts
for the year ended 31 October 2025
Northfield Pharmaceuticals Ltd is a private company, limited by shares, registered in England and Wales, registration number 12983269. The registered office is 10 Northfield Road, Dewsbury, West Yorkshire, WF13 2JX, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Other
At 1 November 2024
304,723
At 31 October 2025
304,723
Charge for the year
30,472
At 31 October 2025
213,307
At 31 October 2024
243,779
Northfield Pharmaceuticals Ltd
Notes to the Accounts
for the year ended 31 October 2025
5
Tangible fixed assets
Plant & machinery
Amounts falling due after more than one year
Trade debtors
92,994
82,794
Other debtors
15,737
12,231
7
Creditors: amounts falling due within one year
2025
2024
Trade creditors
101,166
86,371
Taxes and social security
12,511
18,654
8
Creditors: amounts falling due after more than one year
2025
2024
Other creditors
266,971
288,271
9
Average number of employees
During the year the average number of employees was 0 (2024: 0).